[Chemotherapy of malignant tumors].
D000728:Androgens / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000188:drug therapy; D002066:Busulfan / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008722:Methods; D009369:Neoplasms / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy; D014228:Triaziquone / Q000627:therapeutic use; D014565:Urogenital Neoplasms / Q000188:drug therapy
D000728:Androgens; D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D001215:Asparaginase; D014228:Triaziquone; D002066:Busulfan
Chemotherapie maligner Tumoren